Evidence mapPaperPMID 39788428Full record

SynthesisAmerican journal of obstetrics & gynecology MFM2025

Systematic review of interventions in early pregnancy among pregnant individuals at risk for hyperglycemia.

Larissa Calancie, Madelin O Brown, Wooyon A Choi, Jessica L Caouette, James McCann, Eunice Y Nam, Erika F Werner

Abstract readSystematic Review
In one paragraph

Synthesis in American journal of obstetrics & gynecology MFM, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Larissa CalancieFriedman School of Nutrition Science and Policy, Tufts University, Boston, MA (Calancie, Caouette and McCann). Electronic address: Larissa.calancie@tufts.edu.
Madelin O BrownSchool of Medicine, Tufts University, Boston, MA (Brown, Choi, Nam and Werner).
Wooyon A ChoiSchool of Medicine, Tufts University, Boston, MA (Brown, Choi, Nam and Werner).
Jessica L CaouetteFriedman School of Nutrition Science and Policy, Tufts University, Boston, MA (Calancie, Caouette and McCann).
James McCannFriedman School of Nutrition Science and Policy, Tufts University, Boston, MA (Calancie, Caouette and McCann).
Eunice Y NamSchool of Medicine, Tufts University, Boston, MA (Brown, Choi, Nam and Werner).
Erika F WernerSchool of Medicine, Tufts University, Boston, MA (Brown, Choi, Nam and Werner); Tufts Medical Center, Boston, MA (Werner).

Funding

Tufts BIRCWH ProgramK12AR084217 · TUFTS UNIVERSITY BOSTON · 2025 to 2025
$642k
NIAMS NIH HHS K12 AR084217NICHD NIH HHS K12 HD092535
6 · The paper itself

Abstract

objectiveThe maternal metabolic environment in early pregnancy can influence fetal growth trajectories. Our objective was to identify interventions initiated in early pregnancy (<20 weeks gestation) in pregnant individuals with risk factors for hyperglycemia and report their impact on primary (neonatal adiposity, small for gestational age, large for gestational age, macrosomia) and secondary outcomes (gestational weight gain, maternal hypertensive disorder, birth injury, NICU admission, preterm delivery, emergency cesarean section). DATA SOURCES: We searched Cochrane Central database, Medline, Embase, CINAHL databases, and clinicaltrials.gov (September 2024) for clinical trials published between 2009 and 2024. Search terms included the key words "early OR during" OR "first trimester OR second trimester" AND "gestation OR pregnancy" OR "prenatal care" AND "insulin resistance" OR "metabolic health" OR "diabet*" OR "body composition" OR "obes*" OR "weight gain" OR "gestational diabetes" OR "hyperglycemia" OR "metabolic syndrome" AND "clinical trial." STUDY ELIGIBILITY CRITERIA: Randomized controlled trials (RCTs) and other trials reporting interventions initiated before 20 weeks gestation in participants with singleton pregnancies at risk for hyperglycemia (overweight and/or obesity, history of type 2 diabetes, and/or history of GDM) that reported at least one primary outcome were included. Studies had to be conducted with humans in high income countries as defined by the World Bank, written in English. STUDY APPRAISAL AND SYNTHESIS

methodsWe used the Downs and Black checklist to evaluate the methodological quality and risk. Data was extracted independently and any questions were resolved through group discussion. Interventions were categorized and synthesized by type.

results21,924 records were identified and 70 full-text articles met inclusion criteria. 65 articles were RCTs. Eight intervention categories were identified: diet only, physical activity or exercise only, diet and physical activity or exercise combined, lifestyle counseling, supplements, pharmaceuticals, early GDM screening, and mixed interventions. Only 12 studies reported statistically significant effects on primary neonatal outcomes.

conclusionsInterventions initiated in early pregnancy (<20 weeks) among pregnant individuals at risk for hyperglycemia that include one or more of the following strategies can reduce risk of excess neonatal adiposity, macrosomia, large for gestational age and small for gestational age neonates: goal-setting and motivational strategies to improve diet and increase physical activity through individual and group sessions; lifestyle coaching that included behavioral techniques designed to empower participants by fostering autonomy in a supportive environment; structured group exercise classes three times per week; and personalized dietary recommendations. El resumen está disponible en Español al final del artículo.

Indexed as

HyperglycemiaPregnancy ComplicationsPrenatal CareDiabetes, GestationalFemaleGestational Weight GainHumansInfant, NewbornPregnancyPregnancy OutcomeRandomized Controlled Trials as TopicRisk Factorscounselingdietearly pregnancyexercisefirst trimestergestationgestational diabetes mellitusglucose intolerancehealth disparitieshyperglycemiainterventionlifestylematernal and child healthobesitypharmaceuticalphysical activitypregnancyreviewsupplements

Identifiers

PMID39788428
PMCPMC11885049

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.